Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TYNADOTE + NAC in Acetaminophen Overdose
NCT05557448Phase 2Recruiting
- Sponsor
- Sinew Pharma
- Start
- May 2023
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of SNP-820 in acetaminophen toxicity, sponsored by Sinew Pharma. Started May 2023; status: recruiting.
02
Drugs
SNP-820
03
Conditions
acetaminophen toxicity
Beyond the preview
Go deeper on NCT05557448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05557448.